These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38451692)

  • 21. Autonomic nervous system in the genesis of arrhythmias in chronic heart failure: implication for risk stratification.
    Piepoli MF; Capucci A
    Minerva Cardioangiol; 2007 Jun; 55(3):325-33. PubMed ID: 17534251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Search of the Holy Grail of Artificial Hearts: Are We There Yet?
    Volod O; Colon MJ; Arabía FA
    Semin Thromb Hemost; 2024 Feb; 50(1):104-114. PubMed ID: 37604198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanical dyssynchrony in CRT patients: still searching for the Holy Grail!
    Auricchio A; Faletra FF
    Eur J Heart Fail; 2008 Mar; 10(3):217-9. PubMed ID: 18282742
    [No Abstract]   [Full Text] [Related]  

  • 24. In pursuit of the holy grail.
    Nihoyannopoulos P
    JACC Cardiovasc Imaging; 2015 May; 8(5):523-525. PubMed ID: 25937191
    [No Abstract]   [Full Text] [Related]  

  • 25. Is Grace Risk Score the Holy Grail in Risk Stratification or Can We Improve it Even Further with Additional Biomarkers?
    Timóteo AT
    Arq Bras Cardiol; 2020 Apr; 114(4):673-674. PubMed ID: 32491015
    [No Abstract]   [Full Text] [Related]  

  • 26. In Search of the Holy Grail: Stem Cell Therapy as a Novel Treatment of Heart Failure with Preserved Ejection Fraction.
    Domaszk O; Skwarek A; Wojciechowska M
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanical dyssynchrony in CRT: still searching for the Holy Grail.
    Steffel J; Leclercq C
    Eur Heart J; 2014 Jan; 35(1):13-5. PubMed ID: 24046436
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of heparin-induced thrombocytopenia type II in hemodialysis patients: the search for a Holy Grail continues.
    Goździkiewicz J; Borawski J; Myśliwiec M
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):110-1. PubMed ID: 17164502
    [No Abstract]   [Full Text] [Related]  

  • 29. Targeting the autonomic nervous system: measuring autonomic function and novel devices for heart failure management.
    Patel HC; Rosen SD; Lindsay A; Hayward C; Lyon AR; di Mario C
    Int J Cardiol; 2013 Dec; 170(2):107-17. PubMed ID: 24200312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. More poles and more configurations: seeking the Holy Grail for cardiac resynchronization therapy.
    Baranchuk A; Somani R
    Cardiol J; 2012; 19(5):445-6. PubMed ID: 23042305
    [No Abstract]   [Full Text] [Related]  

  • 31. Sudden cardiac death risk stratification in patients with heart failure.
    Lorvidhaya P; Addo K; Chodosh A; Iyer V; Lum J; Buxton AE
    Heart Fail Clin; 2011 Apr; 7(2):157-74, vii. PubMed ID: 21439495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device.
    Adamson PB; Smith AL; Abraham WT; Kleckner KJ; Stadler RW; Shih A; Rhodes MM;
    Circulation; 2004 Oct; 110(16):2389-94. PubMed ID: 15313946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Search for the Holy (Mesh) Grail Continues.
    Poulose BK
    Surgery; 2021 Aug; 170(2):634. PubMed ID: 33384158
    [No Abstract]   [Full Text] [Related]  

  • 34. Noninvasive imaging of heart failure: neuronal dysfunction and risk stratification.
    Higuchi T; Schwaiger M
    Heart Fail Clin; 2006 Apr; 2(2):193-204. PubMed ID: 17386889
    [No Abstract]   [Full Text] [Related]  

  • 35. Iodine-123-metaiodobenzylguanidine scintigraphy in risk stratification of sudden death in heart failure.
    Martins da Silva MI; Vidigal Ferreira MJ; Morão Moreira AP
    Rev Port Cardiol; 2013 Jun; 32(6):509-16. PubMed ID: 23731734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of response to cardiac resynchronization therapy: the holy grail of electrophysiology.
    Ismail H; Makaryus AN
    Int J Cardiovasc Imaging; 2010 Feb; 26(2):197-8. PubMed ID: 20041306
    [No Abstract]   [Full Text] [Related]  

  • 37. Predictive Biomarkers for Muscle-invasive Bladder Cancer: The Search for the Holy Grail Continues.
    Choudhury A; Hoskin PJ
    Eur Urol; 2019 Jul; 76(1):69-70. PubMed ID: 30732925
    [No Abstract]   [Full Text] [Related]  

  • 38. Biologic markers for cancer: the search for the Holy Grail continues.
    Mauer AM
    J Lab Clin Med; 1992 Dec; 120(6):828-30. PubMed ID: 1453104
    [No Abstract]   [Full Text] [Related]  

  • 39. N-terminal proBNP: a novel biomarker for the diagnosis, risk stratification and management of congestive heart failure.
    O'Donoghue M; Januzzi JL
    Expert Rev Cardiovasc Ther; 2005 May; 3(3):487-96. PubMed ID: 15889976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional Cardiac Sympathetic Nervous System Evaluation Using 123I-mIBG SPECT in Patients with Heart Failure.
    Iqbal B; Currie G; Kiat H
    J Med Imaging Radiat Sci; 2018 Dec; 49(4):397-405. PubMed ID: 30514557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.